Primary myelofibrosis

• Phase 2 Study of Momelotinib in Combination with Luspatercept in Participants with Transfusion Dependent Myelofibrosis. Pending
  2024-518225-15-00 4 "Myelofibrosis"
• A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t … Pending
  2025-523555-66-00 5 "Myelofibrosis"
• HOVON 172 MF: Study on tasquinimod treatment in patients with myelofibrosis Recruitment ended
  2024-511565-11-00 9 2025-02-12 "Myelofibrosis"
• A Study to Evaluate Single Agent Selinexor Versus Physician's Choice in Participants with Previously Treated Myelofibrosis Recruitment ended
  2024-513605-31-00 4 2021-10-21 "Myelofibrosis"
• A study to evaluate the benefit and safety of Luspatercept (ACE-536) in adults with myeloproliferative neoplasm-associated myelofibrosis on … Recruitment ended
  2023-507890-17-00 5 2021-02-22 "Anemia associated with myeloproliferative neoplasm (MPN)-ass"
• Study of the Safety and Efficacy of KRT-232 Combined with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post–Polycythemia Vera M … Recruitment ended
  2024-514468-26-00 9 2020-12-04 "Primary Myelofibrosis (PMF), Post–Polycythemia Vera MF (Post"
• PACIFICA: A Phase 3 Study of Pacritinib in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thro … Recruitment ended
  2024-515953-52-00 5 2020-07-24 "Post-Essential Thrombocythaemia Myelofibrosis"
• A phase 3B, open-label, single-arm, rollover study to evaluate long-term safety of Luspatercept in subjects who have participated in other L … Recruitment ended
  2022-502498-40-00 5 2019-07-26 "myelodysplastic syndrome (MDS); beta (β)-thalassemia (THAL);"
• KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treat … Recruitment ended
  2024-513912-89-00 10 2018-12-13 "Primary Or Secondary (Post-PV MF or Post-ET-MF) Myelofibrosi"

Showing 1–9 of 9 trials